UBS Maintains $235 Price Target on Nvidia

1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$235
Outcome
Reached
on May 14, 2026

UBS’s latest target on NVIDIA is now $300 (Oct 9, 2026); the median of 28 firms is $315. UBS has reached 81% of its year-old targets (54 scored).

UBS and NVIDIA logos

What the analyst said

UBS analyst Timothy Arcuri reiterated on November 20, 2025, a ‘Buy’ rating and $235 price target on Nvidia.

“Consistent w/our preview, NVDA’s guidance was very solid (even better than our $63-64B) with demand commentary delivering another full throated message that the market is too concerned about any “bubble” that may be forming.

While still probably prudent to allow for some supply chain uncertainty, it is not rocket science to take total backlog and shipment commentary from the company and back into $350-400B in revenue and >$9 in EPS for C2026 – and it sounds like there is still time for this number to move even higher.

Probably the most encouraging thing to us was that NVDA’s “supply” grew a significant~$25B Q/Q to ~$70B.

History suggests this number is usually ~80-90% of the following Q’s revenue – and yet NVDA is “only” guiding FQ4 to $65B.

To us, this means that NVDA could do $75-80B in FQ1 (April) revenue even if this “supply” number did not grow at all when it reports FQ4.

The Street does not have $80B in revenue until FQ4:27 (Jan ’27), meaning big upward revisions are apt to continue.

Given all of this, odds are very high that EPS is up again substantially in C2027 (we now model ~$11 vs. Street ~$8.50) so on these numbers, it is very hard to see how this stock does not keep moving higher from here.

Ultimately, the AI infrastructure tide is still rising so fast that all boats will be lifted, but NVDA seems to be actually tightening its grip on broadly enabling AI across modalities (text, video, etc..) and industries.

We are increasing estimates yet again (C2026 to ~$8.70, C2027 to ~$11) which, even assuming the stock will trade a low 20x multiple, and we maintain our $235 PT.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

NVDA trades at $169. The 28 analysts who set a target in the last 3 months range from $250 to $515, with a median of $315. This $235 target is 25% below the median, the lowest on the Street.

Since the note NVDA has moved −9% (from $187). 12-month window: day 355 of 365, closes on November 20, 2026.

Track record

This call✓ Target reached on May 14, 2026, 6 months after the note. Same target as this firm’s October 29, 2025 note, so it is scored there.

Firm track recordUBS: 81% of its 54 targets at least a year old were reached within 12 months (#9 of 26 firms); on NVIDIA, 6 of 6. Accuracy ranking →

Earnings reactionOne of 27 notes after NVIDIA’s Nov 19 results: 17 raised · 0 cut · 8 kept. See every call →

UBS on NVIDIA

UBS price targets on NVIDIA

8 calls from August 28, 2025 to January 6, 2026. The target went from $205 to $235 (+15%). The rating stayed Buy.

UBS targetNVDA share price
  1. January 6, 2026Kept the $235 targetBuy$235
  2. December 29, 2025Kept the $235 targetBuy$235
  3. December 9, 2025Kept the $235 targetBuy$235
  4. November 20, 2025 This noteKept the $235 targetBuy$235
  5. October 29, 2025Target raised from $205 (+15%)Buy$235
  6. October 10, 2025Kept the $205 targetBuy$205
  7. September 23, 2025Kept the $205 targetBuy$205
  8. August 28, 2025Earliest call shownBuy$205
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.